Chiron Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$223K Sell
1,204
-1,766
-59% -$303K 0.19% 105
2025
Q2
$454K Buy
2,970
+709
+31% +$109K 0.39% 67
2025
Q1
$375K Sell
2,261
-2
-0.1% -$313 0.34% 72
2024
Q4
$327K Sell
2,263
-800
-26% -$124K 0.31% 83
2024
Q3
$496K Sell
3,063
-1,954
-39% -$311K 0.44% 59
2024
Q2
$733K Buy
+5,017
New +$746K 0.7% 39
2023
Q3
Sell
-2,020
Closed -$334K 120
2023
Q2
$334K Sell
2,020
-4,880
-71% -$788K 0.26% 73
2023
Q1
$1.07M Buy
+6,900
New +$1.11M 0.74% 30
2021
Q3
Sell
-1,300
Closed -$214K 102
2021
Q2
$214K Buy
+1,300
New +$215K 0.18% 74
2020
Q4
Sell
-900
Closed -$134K 258
2020
Q3
$134K Buy
+900
New +$133K 0.11% 89

Other funds holding JNJ

Chiron Capital Management's JNJ Position: Q3 2025 in Review

Chiron Capital Management reduced its Johnson & Johnson (JNJ) stake by 59% in Q3 2025, selling an estimated $303K and leaving 1,204 shares worth $223K. The position accounts for 0.19% of the portfolio, ranked #105.

Chiron Capital Management first reported a position in JNJ in Q3 2020 and has held it in 10 quarters since. The position peaked at $1.07M in Q1 2023. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Chiron Capital Management held 1,204 shares of Johnson & Johnson worth $223K as of Q3 2025.
  • Chiron Capital Management sold 1,766 Johnson & Johnson shares in Q3 2025, an estimated $303K.
  • Johnson & Johnson made up 0.19% of Chiron Capital Management's portfolio in Q3 2025, its #105 holding.
  • Chiron Capital Management first reported a position in Johnson & Johnson in Q3 2020 and has held it in 10 quarters since.
  • Chiron Capital Management's Johnson & Johnson position peaked at $1.07M in Q1 2023.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Chiron Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.